Interestingly, upregulated TRIM25 expression is usually detected in many types of tumor cells, especially in hormone-responsive tumors, such as breast cancer, prostate cancer, ovarian cancer, and endometrial cancer, because of its estrogen-responsive characteristics [18]. Here, TRIM25 is linked to endometrial cancer.